Advertisement

Clinical and Experimental Nephrology

, Volume 11, Issue 3, pp 238–240 | Cite as

Acute renal failure due to interstitial nephritis after intravesical instillation of BCG

  • Maria Jose Manzanera Escribano
  • Enrique Morales RuizEmail author
  • Mónica Odriozola Grijalba
  • Eduardo Gutierrez Martínez
  • Alfredo Rodriguez Antolín
  • Manuel Praga Terente
CASE REPORT

Abstract

Intravesical chemotherapy with bacilli Calmette-Guerin (BCG) has been an established therapy for preventing recurrence of, and for treatment of, superficial transitional cell carcinoma of the bladder, but it is not without side effects. A variety of renal complications have been reported and attributed to mycobacterial infection. Although renal complications are uncommon, several cases of interstitial nephritis (with or without granulomas) and mesangial glomerulonephritis have been reported. We report a 76-year-old male patient who developed acute renal failure due to interstitial nephritis after intravesical instillation of BCG. Corticosteroids may serve the recovery of renal function without concomitant use of anti-tubercular therapy, provided systemic signs and mycobacterial infection are absent. Serum creatinine should be checked in at-risk patients in order to detect this complication early.

Key words

Interstitial nephritis BCG Carcinoma of the bladder Acute renal failure Steroid treatment 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Meyer, JP, Persad, R, Gillat, DA 2002Use of bacilli Calmette-Guérin in superficial bladder cancerPostgrad Med J7844954CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Lamm, DL 2000Efficacy and safety of bacille Calmette-Guerin immunotherapy in superficial bladder cancerClin Infect Dis31S8690CrossRefPubMedGoogle Scholar
  3. 3.
    Lamm, DL, van der Neijden, PM, Morales, A, Brosman, SA, Catalona, WJ, Herr, HW,  et al. 1992Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancerJ Urol147596600CrossRefPubMedGoogle Scholar
  4. 4.
    Scully, RE, Mark, EJ, McNeely, WF, Ebeling, SH 1998Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29–1998N Engl J Med3398317CrossRefGoogle Scholar
  5. 5.
    Modesto, A, Marty, L, Suc, JM, Kleinknecht, D, De Fremont, JF, Marsepoil, T,  et al. 1991Renal complications of intravesical bacillus Calmette-Guérin therapyAm J Nephrol115014CrossRefPubMedGoogle Scholar
  6. 6.
    Binaut, R, Bridoux, F, Provót, F, Daniel, N, Fleury, D, Mougenot, B,  et al. 1997Granulomatous interstitial nephritis with acute renal insufficiency, a potential complication of intravesicular BCG therapyNéphrologie1818791PubMedGoogle Scholar
  7. 7.
    Fry, A, Saleemi, A, Griffiths, M, Farrington, K 2005Acute renal failure following intravesical bacilli Calmette-Guerin chemotherapy for superficial carcinoma of bladderNephrol Dial Transplant2084950CrossRefPubMedGoogle Scholar
  8. 8.
    Kennedy, SE, Shrikanth, S, Charlesworth, JA 2006Acute granulomatous tubulointerstitial nephritis caused by intravesical BCGNephrol Dial Transplant2114279CrossRefPubMedGoogle Scholar
  9. 9.
    Bohle, A, Brandau, S 2003Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancerJ Urol1709649CrossRefPubMedGoogle Scholar
  10. 10.
    Prescott, S, Jackson, AM, Hawkyard, SJ, Alexandroff, AB, James, K 2000Mechanisms of action of intravesical bacilli Calmette-Guerin: local immune mechanismsClin Infect Dis31S913CrossRefPubMedGoogle Scholar
  11. 11.
    Elkabani, M, Greene, JN, Vincent, AL, VanHook, S, Sandin, RL 2000Disseminated Mycobacterium after intravesicular bacillus Calmette-Guerin treatments for bladder cancerCancer Control747681CrossRefPubMedGoogle Scholar
  12. 12.
    Molina, JM, Rabian, C, D' Agay, MF, Modai, J 1992Hypersensivity systemic reaction following intravesical bacillus Calmette-Guerin: successful treatment with steroidsJ Urol1476957CrossRefPubMedGoogle Scholar
  13. 13.
    Rawis, WH, Lamm, DL, Lowe, BA, Crawford, ED, Sarosdy, MF, Montie, JE,  et al. 1990Fatal sepsis following intravesical bacillus Calmette-Guerin administration for bladder cancerJ Urol144132830CrossRefGoogle Scholar
  14. 14.
    González, OY, Musher, DM, Brar, I, Furgerson, S, Boktour, MR, Septimus, EJ,  et al. 2003Spectrum of Bacille Calmette-Guerin (BCG) infection after intravesical BCG immunotherapyClin Infect Dis151408CrossRefGoogle Scholar
  15. 15.
    McParland, C, Cotton, DJ, Gowda, KS, Hoeppner, VH, Martin, WT, Weckworth, PF 1992Miliary Mycobacterium bovis induced by intravesical bacilli Calmette-Guerin immunotherapyAm Rev Respir Dis14613303CrossRefPubMedGoogle Scholar
  16. 16.
    González, E, Gutierrez, E, Gutierrez, E, Hernández, E, Morales, E, Praga, M 2005Allergic interstitial nephritis. When should steroid treatment be initiated?J Am Soc Nephrol16782ACrossRefGoogle Scholar
  17. 17.
    Meijden, AP Brausi, M Zambon, M Kirkels, W De Balincourt, C Silvestre, R Members of the EORTC Genito-urinary Group2001Intravesical instillation of epirubicin, bacillus Calmette-Guerin and bacillus Calmette-Guerin plus isoniazid for intermediate and high risk Ta, T1 papillary carcinoma of bladder: a European Organization for Research and Treatment of Cancer Genito-urinary Group randomized phase III trialJ Urol16647681CrossRefPubMedGoogle Scholar

Copyright information

© Japanese Society of Nephrology 2007

Authors and Affiliations

  • Maria Jose Manzanera Escribano
    • 1
  • Enrique Morales Ruiz
    • 1
    Email author
  • Mónica Odriozola Grijalba
    • 1
  • Eduardo Gutierrez Martínez
    • 1
  • Alfredo Rodriguez Antolín
    • 2
  • Manuel Praga Terente
    • 1
  1. 1.Nephrology DepartmentHospital 12 de OctubreMadridSpain
  2. 2.Urology DepartmentHospital 12 de OctubreMadridSpain

Personalised recommendations